Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。